Navigation Links
ThreeWire Expands Presence in the Pharmaceutical Arena
Date:5/27/2008

Utilizes extensive experience in medical device industry to benefit

pharmaceutical clinical trial recruitment efforts

MINNEAPOLIS, May 27 /PRNewswire/ -- Leading clinical trial recruitment and direct-to-patient marketing firm ThreeWire has strengthened the pharmaceutical side of its business with the addition of two directors of business development and a commitment to leveraging differentiators unique to the medical device industry on behalf of pharmaceutical industry clients.

According to ThreeWire CEO and President, Mark Summers, "In the world of medical device clinical research studies, you have to motivate patients to agree to have a device surgically implanted in their body. Add to that a restrictive protocol, and you are now recruiting from a narrow, hard-to-reach patient population that must be prepared to undergo a highly invasive surgical procedure. Success depends on a system that targets only the most qualified patients and keeps them engaged throughout the healthcare continuum. It is that experience we are using to drive enrollment for pharmaceutical clinical trials."

In order to help pharmaceutical companies in their patient recruitment efforts, ThreeWire has hired Janine Katz and Shannon McDonnell. Katz is a business development professional with over ten years of experience in clinical trial patient recruitment and public relations programs in the pharmaceutical and healthcare industries. McDonnell brings leadership skills in business development in the healthcare field, including two years focused solely on clinical trial recruitment. Both will report to Jim Suddendorf, Senior Vice President, Business Development and Client Services.

"As the regulatory bar is being raised and greater numbers of patients are being required for trial completion, the challenge of patient recruitment is being elevated," adds Suddendorf. "Successful enrollment solutions depend on a systematic marketing approach, which is exactly what ThreeWire offers."

To deliver results, ThreeWire offers a full array of in-house services, including concept development, advertising, media planning and buying, and optimized website development, as well as site-based support and portal tools. Contract study coordinators can conduct patient record screenings, process patient referrals and assist with informed consent. ThreeWire also features a multi-lingual nurse-staffed call center and grassroots outreach.

For more information, contact sales@threewire.com.

Since 1999, ThreeWire has been delivering premier services and offering strategic and tactical solutions that result in measurable growth, global brand recognition and market leadership to the medical device, pharmaceutical and biotech industries. In addition to clinical trial recruitment and direct-to-patient marketing, ThreeWire also offers Recall Response Services with 24/7 call center capabilities.

For more information, contact:

Annie Garvey

952-852-5572

agarvey@threewire.com


'/>"/>
SOURCE ThreeWire
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
2. DuPont Expands Animal Health Solutions Business in Asia
3. Hospira Expands Board of Directors
4. Sidec AB Expands Into New Offices
5. Angiotech Expands Quill(TM) SRS product offering receiving FDA 510(k) approval for smaller size diameters of Quill(TM) SRS PDO
6. SAFC Hitech(TM) Expands Sheboygan Facility With State-of-the-Art Manufacturing Cleanroom
7. Quintiles Consulting Business Expands
8. REVISED: BrainCells Inc. Expands Series B Financing to $50 Million
9. BrainCells Inc. Expands Series B Financing to $50 Million
10. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
11. SeqWright Expands Next Generation Lineup with the Addition of 454s GS FLX(TM) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... KING OF PRUSSIA, PA (PRWEB) , ... December 01, 2016 , ... ... clinical research is through industry-wide collaboration, standardization and a beautiful technology experience. All three ... which convened more than 100 clinical trial leaders from over 40 sponsor, CRO and ...
(Date:12/2/2016)... Dec. 1, 2016   SurePure, Inc. (OTCQB: ... that the Company has concluded an agreement with Tamarack ... a 90-day period to acquire units of the Company,s ... USD 3.7 million.  Concurrently with the ... under which Tamarack will seek regulatory approvals in ...
(Date:11/30/2016)... announced the appointment of Joshua F. Coleman , M.D., ... Coleman will oversee clinical content development and curation of scientific ... suite empowers molecular pathologists with a seamless workflow for the ... quality control through reporting. ... , , Prior ...
(Date:11/30/2016)... Nov. 30, 2016  The Allen Institute for ... the first publicly available collection of gene edited, ... target key cellular structures with unprecedented clarity. Distributed ... powerful tools are a crucial first step toward ... understand what makes human cells healthy and what ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:11/14/2016)... Inc. ("xG" or the "Company") (Nasdaq: XGTI, XGTIW), a ... challenging operating environments, announced its results for the third ... conference call to discuss these results on November 15, ... Key Recent Accomplishments The ... Vislink Communication Systems. The purchase is expected to close ...
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Biology News(10 mins):